Docoh
Loading...

Gary Sender

Gary Sender is Chief Financial Officer of Nabriva Therapeutics Plc.

Person profile

Roles
Nabriva Therapeutics Chief Financial Officer
iBio Director
Schrodinger Director
Address
New York, New York
Employees
SEC CIK

Calendar

17 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Dec 21 IBIO iBio Stock Option Common Stock Grant Acquire A No No 0.6938 109,000 75.62K 109,000
17 Jun 21 SDGR Schrodinger Stock Option Common Stock Grant Acquire A No No 76.08 8,736 664.63K 8,736
20 May 21 HRMY Harmony Biosciences Stock Option Common Stock Grant Acquire A No No 32.5 13,333 433.32K 13,333
8 Mar 21 SDGR Schrodinger Common Stock Sell Dispose S No No 66.5452 28,775 1.91M 0
8 Mar 21 SDGR Schrodinger Common Stock Option exercise Acquire M No No 17 12,890 219.13K 28,775
8 Mar 21 SDGR Schrodinger Common Stock Option exercise Acquire M No No 5.31 15,885 84.35K 15,885
8 Mar 21 SDGR Schrodinger Stock Option Common Stock Option exercise Dispose M No No 17 12,890 219.13K 19
8 Mar 21 SDGR Schrodinger Stock Option Common Stock Option exercise Dispose M No No 5.31 15,885 84.35K 24,246
28 Feb 21 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 2.39 31 74.09 20,472

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings